IP Library Granted Patent US 11,141,371
Granted Patent B2
US 11,141,371 · App. 15/504,055 · Granted Oct 12, 2021

Extracts of

Inventors: Lorenzo Zanella (Mestre-Venezia, IT); Paolo Pertile (San Pietro Viminario, IT)
Assignee: Symrise AG
A61K8/9706A61K8/9767A61K8/9771A61K8/9789A61K8/9794A61K36/05A61Q5/006A61Q7/00A61Q19/00A61Q19/008A61K2236/33A61K2236/331A61K2236/37A61Q5/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,141,371
App. No.
15/504,055
Granted
Oct 12, 2021
Kind
B2
Abstract

New extracts of Nannochloropsis sp. and related species of Nannochloropsis are suggested, obtainable by treating said microalgae with a solvent selected from the group consisting of C 1 -C 1 aliphatic alcohols, ethyl acetate, water or their mixtures, removing the dissolved extracts from the residues and recovering the pure extracts from the solvent. The extracts show excellent properties particularly in modulating the metabolism of human skin and hair follicles.

Claims (29)

1. A method for the treatment of a human hair or skin condition selected from the group consisting of human skin melanogenesis, skin hyperpigmentation, skin spots, hair loss, hypodermal disorders, cellulite, reducing growth of human hair, and adipocyte metabolism comprising topically administering on the skin or scalp of a subject in need thereof, an extract of Nannochloropsis sp. obtained by the steps of:

(a) bringing microalgae in contact with a solvent selected from the group consisting of C1-C4 aliphatic alcohols, ethyl acetate, and mixtures thereof, and mixtures of C1-C4 aliphatic alcohols with water, in an amount suitable to make active move into the solvent phase,

(b) removing the dissolved extract from the residue, and

(c) recovering the pure extract from the solvent,

in an amount effective for fighting or preventing disorder or dysfunction connected to human skin melanogenesis, or skin hyperpigmentation and spots, or

hypodermal disorders by modulation of adipocyte metabolism, or

cellulite,

in an amount effective for modulating

growth of human hair, or

the adipocyte metabolism, or

the skin melanogenesis.

2. The method according to claim 1 , comprising (a) extracting with a mixture of two or more of said solvents.

3. The method according to claim 1 , wherein (a) the solvent is ethyl acetate.

4. The method according to claim 1 , wherein (a) the solvent is ethanol.

5. The method according to claim 1 , wherein the extract of Nannochloropsis sp.is combined with a cosmetically acceptable carrier selected from the group consisting of C1-C4 aliphatic alcohols, polyols having 3 to 12 carbon atoms, oil components, water, and mixtures thereof.

6. The method according to claim 1 , wherein Nannochloropsis sp. are N. granulate, N. limnetica, N. oceanica or N. oculata.

7. A method for the treatment of a human hair or skin condition selected from the group consisting of human skin melanogenesis, skin hyperpigmentation, skin spots, hair loss, hypodermal disorders, cellulite, reducing growth of human hair, and adipocyte metabolism consisting of topically administering on the skin or scalp of a subject in need thereof, an extract of Nannochloropsis sp. obtained by the steps consisting of:

(a) bringing microalgae in contact with a solvent selected from the group consisting of C1-C4 aliphatic alcohols, ethyl acetate, and mixtures thereof, and mixtures of C1-C4 aliphatic alcohols with water, in an amount suitable to make active move into the solvent phase,

(b) removing the dissolved extract from the residue, and

(c) recovering the pure extract from the solvent,

in an amount effective for fighting or preventing

disorder or dysfunction connected to human skin melanogenesis, or

skin hyperpigmentation and spots, or

hypodermal disorders by modulation of adipocyte metabolism, or

cellulite,

in an amount effective for modulating

growth of human hair, or

the adipocyte metabolism, or

the skin melanogenesis.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2020
From: SYMRISE SRL
To: SYMRISE AG
Reel/Frame 052298/0095 →
MERGER AND CHANGE OF NAME Recorded Apr 1, 2020
From: CUTECH SRL; SYMRISE SRL
To: SYMRISE SRL
Reel/Frame 052305/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2017
From: ZANELLA, LORENZO; PERTILE, PAOLO
To: CUTECH SRL
Reel/Frame 042058/0801 →
Priority Claims (1)
EP 14181355 · Aug 19, 2014 · regional
Continuity (1)
Related Publication 20170246229A1 · Aug 31, 2017